Funding · 4 February 2026Elevate Now₹18 Cr (~$2 Mn)Online weight management subscription service
FundingHealthcare & Life Sciences
Elevate Now raises ₹18 crore seed round led by Physis Capital
By Abha Lohia · Editor ·
seedFounded 2022
- Elevate Now offers subscription-based online weight loss programs with personalized support and GLP-1 drugs
- The company raised ₹18 crore in seed funding to strengthen its technology stack and expand clinical research capabilities
- With over 30,000 paid users and strong monthly growth, it competes in India's projected $100 billion anti-obesity market
What happened
- Elevate Now has raised ₹18 crore (approximately $2 million) in a seed funding round.
- Physis Capital led the investment round for the health-tech startup.
- Inflection Point Ventures and Titan Capital participated in the funding round.
- The company plans to use the funds to strengthen its tech stack and develop nutritional supplements.
- Elevate Now aims to expand its clinical research and build personalization systems using the new capital.
- Suryansh Kumar founded Elevate Now after working as an executive at Swiggy.
- The startup currently serves more than 30,000 paid users across its platform.
- Revenue grew by an average of 17% month-on-month between April 2025 and January 2026.
Why it matters
- Elevate Now operates in a sector where the India anti-obesity drugs market is projected to reach $100 billion by 2030.
- The company faces competition from established players like Healthify and HealthifyRx.
- This funding follows a previous raise of $1.8 million from W Health Ventures and Narayana Health.
- The investment highlights growing interest in medically-assisted weight loss solutions in India.
The business
- Elevate Now provides subscription-led online weight management programmes to its customers.
- The platform offers personalized support and therapies for weight loss goals.
- Users receive guidance on nutrition, fitness, and stress management through the service.
- Elevate Now prescribes GLP-1 drugs for medically-assisted weight loss under supervision.
- The business model relies on recurring revenue from user subscriptions.
- The company focuses on building a robust tech stack to support its services.
- Elevate Now integrates clinical research into its core operational framework.
- The startup targets individuals seeking structured and medically supervised weight loss journeys.
- It competes directly with other digital health platforms offering similar weight management tools.
The founders
SK
Suryansh Kumar
Founder- Suryansh Kumar previously worked as an executive at Swiggy.
- He founded Elevate Now to address the growing demand for digital weight management solutions.
- His background includes experience in scaling consumer-facing technology platforms.
Who put in money
- Physis Capital lead — Venture capital firm leading the seed round for Elevate Now.
- Inflection Point Ventures participated — Investment firm participating in the seed funding round.
- Titan Capital participated — Investment firm participating in the seed funding round.
In numbers
>30,000Paid Users · 2026
17% month-on-monthRevenue Growth · Apr 2025-Jan 2026
₹18 Cr (~$2 Mn)Funding Amount · 2026
$1.8 MnPrevious Funding
What happens next
- Elevate Now will strengthen its technology infrastructure to improve user experience.
- The company plans to develop new nutritional supplement products for its users.
- Elevate Now intends to expand its clinical research capabilities significantly.
- The startup aims to build advanced personalization systems for better health outcomes.
Earlier rounds
- Prior Round · $1.8 Mn · led by W Health Ventures
Up against
HealthifyHealthifyRx
Words to know
- GLP-1 drugs
- Medications that help regulate blood sugar and promote weight loss by mimicking hormones that control appetite.
- Seed funding
- Early-stage capital invested in a startup to help it develop its product and prove its business model.
The numbers around it
Healthcare & Life Sciences in February 2026: 18 rounds with a disclosed amount, $66.5 million in all; the biggest was Pandorum Technologies ($18M). Every sector this year →
Other articles talking about it
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
- IPO subscription: IPO subscription is the number of times investors bid for the shares on offer. A subscription of 50 times, written 50x, means bids were worth fifty times the shares available in that portion. It shows demand, not the quality of the company or the price after listing.
- Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
All startup news on 4 February 2026 →
Is this Elevate Now? Get your “Featured on StopDown” badge →